Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
99,1 CHF | -0,96 % |
|
+1,93 % | +16,77 % |
15/07 | Les entreprises européennes suppriment des emplois alors que l'économie s'essouffle | RE |
15/07 | Du sang et de la fureur | ![]() |
Métier
- oncologie (29,9%) ;
- immunologie (17,2%) ;
- maladies cardio-vasculaires, rénales et métaboliques (14,1%) ;
- neuroscience (8,9%) ;
Le solde du CA (29,9%) concerne l'activité de fabrication en sous-traitance de produits pharmaceutiques.
A fin 2023, Novartis AG dispose de 33 sites de production dans le monde.
La répartition géographique du CA est la suivante : Europe (33%), Etats-Unis (39,5%), Asie-Afrique-Australasie (20,5%), Canada et Amérique latine (7%).
Nombre d'employés: 76 057
Ventes par activité
CHF en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Established Brands
30,0
%
| - | - | 12 238 | 30,0 % | - |
Oncology
29,9
%
| - | - | 12 213 | 29,9 % | - |
Immunology
17,2
%
| - | - | 7 008 | 17,2 % | - |
Cardiovascular, Renal and Metabolic
14,1
%
| - | - | 5 743 | 14,1 % | - |
Neuroscience
8,9
%
| - | - | 3 633 | 8,9 % | - |
Ventes par région
CHF en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
39,5
%
| 16 860 | 34,9 % | 16 139 | 39,5 % | -4,28 % |
Europe
18,9
%
| 10 469 | 21,7 % | 7 704 | 18,9 % | -26,41 % |
Asia/Africa/Australasia
9,1
%
| 4 975 | 10,3 % | 3 700 | 9,1 % | -25,63 % |
Germany
7,4
%
| 4 086 | 8,5 % | 3 026 | 7,4 % | -25,94 % |
China
7,2
%
| 2 987 | 6,2 % | 2 936 | 7,2 % | -1,73 % |
Canada and Latin America
7,0
%
| 3 709 | 7,7 % | 2 854 | 7,0 % | -23,04 % |
Japan
4,2
%
| 2 106 | 4,4 % | 1 729 | 4,2 % | -17,90 % |
France
3,8
%
| 2 156 | 4,5 % | 1 572 | 3,8 % | -27,09 % |
Switzerland
2,9
%
| 926 | 1,9 % | 1 175 | 2,9 % | +26,88 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 48 | 01/01/05 | |
Director of Finance/CFO | 59 | 01/01/03 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 16/05/22 |
Steffen Lang
COO | Chief Operating Officer | 57 | 01/04/17 |
Klaus Moosmayer
CMP | Compliance Officer | 56 | 01/12/18 |
Samir Shah
IRO | Public Communications Contact | 63 | 01/01/04 |
Simon Brown
PRN | Corporate Officer/Principal | - | 01/08/13 |
Kees Roks
AUD | Comptroller/Controller/Auditor | 61 | 01/05/22 |
Linda Kanitra
PRN | Corporate Officer/Principal | - | - |
Robert Kowalski
HRO | Human Resources Officer | 56 | 01/09/21 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 01/01/13 |
Simon Moroney
BRD | Director/Board Member | 65 | 28/02/20 |
Chairman | 68 | 01/01/13 | |
John Young
BRD | Director/Board Member | 60 | 07/03/23 |
Bridgette Heller
BRD | Director/Board Member | 62 | 28/02/20 |
Ton Büchner
BRD | Director/Board Member | 59 | 01/01/16 |
Charles Sawyers
BRD | Director/Board Member | 65 | 01/01/13 |
Nancy Andrews
BRD | Director/Board Member | 65 | 01/01/15 |
Patrice Bula
BRD | Director/Board Member | 68 | 28/02/19 |
Frans van Houten
BRD | Director/Board Member | 64 | 28/02/17 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 2 189 930 497 | 1 866 336 959 ( 85,22 %) | 233 443 766 ( 10,66 %) | 85,22 % |
Participations
Nom | Actions | % | Valorisation |
---|---|---|---|
NOVARTIS AG 6,63% | 145 083 991 | 6,63% | 15 527 183 237 $ |
MORPHOSYS AG 51,00% | 19 235 376 | 51,00% | 1 393 608 762 $ |
SANDOZ GROUP AG 2,99% | 12 886 900 | 2,99% | 466 659 005 $ |
NOVARTIS INDIA LIMITED 70,68% | 17 450 680 | 70,68% | 231 036 358 $ |
THIRD HARMONIC BIO, INC. 6,45% | 2 642 762 | 6,45% | 34 355 906 $ |
ERASCA, INC. 4,74% | 12 307 692 | 4,74% | 29 046 153 $ |
OCULIS HOLDING AG 4,11% | 1 713 521 | 4,11% | 20 476 576 $ |
MOLECULAR PARTNERS AG 4,74% | 1 739 130 | 4,74% | 12 618 658 $ |
413 581 | 5,97% | 4 024 143 $ |
Coordonnées société
![Adresse Novartis AG(NOVN)](https://cdn.zonebourse.com/static/address/9364983.png)
Sociétés du groupe
Nom | Catégorie et Secteur |
---|---|
Novartis Healthcare Pvt Ltd.
![]() Novartis Healthcare Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Healthcare Pvt Ltd. is an Indian company that manufactures and markets health care and nutritional products. The company is based in Mumbai, India. The company was founded in 1997. The CEO is Sanjay Prabhakar Murdeshwar. |
Pharmaceuticals: Major
|
Novartis Pharma AG
![]() Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. |
Pharmaceuticals: Major
|
Novartis Investment Ltd.
| |
Novartis Holding AG
![]() Novartis Holding AG Financial ConglomeratesFinance Part of Novartis AG, Novartis Holding AG is a Swiss healthcare company that provides solutions to address the evolving needs of patients worldwide. The company is based in Basel, Switzerland. Novartis Holding specializes in Managed Access Programs and is committed to the discovery, development, and marketing of innovative products to improve the well-being of all Canadians. The company prides itself on its commitment to diversity and to nurturing an inclusive and inspiring environment. |
Financial Conglomerates
|
Novartis International AG
![]() Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. |
Pharmaceuticals: Major
|
Novartis Services, Inc.
| |
Novartis Finance SA
|
Finance/Rental/Leasing
|
Novartis BioVenturesAG
![]() Novartis BioVenturesAG Investment ManagersFinance Part of Novartis AG, Novartis BioVenturesAG is an alternative investment manager. The company is based in Basel, Switzerland. |
Investment Managers
|
Novartis Investments SARL
![]() Novartis Investments SARL Financial ConglomeratesFinance Novartis Investments SARL is an investment holding company with interest in medicines and pharmaceuticals sector. The company was founded on July 05, 2002 and is headquartered in Luxembourg. |
Financial Conglomerates
|
Secteur
Ventes par activité
Ventes par région
![Consensus](/images/consensus_flch.gif)
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+16,77 % | 228 Md | |
+63,05 % | 854 Md | |
+39,42 % | 636 Md | |
-4,78 % | 361 Md | |
+17,52 % | 324 Md | |
+8,43 % | 301 Md | |
+14,19 % | 247 Md | |
+5,81 % | 230 Md | |
+14,63 % | 177 Md | |
+1,08 % | 164 Md |
- Bourse
- Actions
- Action NOVN
- Société Novartis AG